FDA expected to approve Pfizer-BioNTech's COVID-19 vaccine by early September: NYT

FDA expected to approve Pfizer-BioNTech's COVID-19 vaccine by early September: NYT

Business Insider

Published

The pharmaceutical company filed its application with the FDA on May 7, and the FDA is expected to finish it's approval process by Labor Day weekend.

Full Article